Members of the UNC Lineberger Comprehensive Cancer Center will share their research and expertise at the 105th Annual Meeting of the American Association for Cancer Research (AACR) on April 5 to 9 in San Diego, Calif. The event will host more than 18,000 researchers, patient advocates and other professionals in the cancer field to share the year’s foremost basic science, translational and clinical advances.
Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
The University of North Carolina at Chapel Hill will dedicate Marsico Hall (formerly called the IRB building or the BRIC building) at 3:30 p.m. Thursday, March 27. The event will also begin streaming live online once the ceremony has begun.
RNA encodes the proteins that play a key role in cellular reproduction, but the manner in which cells regulate its removal once these proteins are synthesized remains a mystery. One piece of this mystery has been solved as researchers at the University of North Carolina at Chapel Hill who have identified the steps by which a cell removes RNA from the cytoplasm.
The Metastatic Breast Cancer Network (MBCN) is pleased to announce it will hold its 8th Annual National Conference September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina
Andrew Olshan, PhD, professor and chair of the UNC Gillings School of Global Public Health’s Department of Epidemiology and UNC Lineberger associate director for population sciences, has been named the Barbara Sorenson Hulka Distinguished Professor of Cancer Epidemiology, effective March 1.
A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member.
On March 5, Shelia Santacroce, PhD, UNC Lineberger Comprehensive Cancer Center Member and Beerstecher-Blackwell Distinguished Scholar, received a $50,000 research grant from Northwestern Mutual and the Alex’s Lemonade Stand Foundation (ALSF) to fund children’s cancer research.
Chad Ellis, PhD, has been appointed as associate director of UNC Lineberger Comprehensive Cancer Center, effective April 1, 2014.
Cancer patients who receive care from local physicians partnering with the medical research community are as likely to receive innovative treatments compared to patients treated at medical school affiliated hospitals, according to research from the University of North Carolina at Chapel Hill.
Across the country, thousands have taken part in the Colon Cancer Coalition’s initiative called “Get Your Rear In Gear,” a series of 5K races aimed at fighting colon cancer by raising funding to support education, prevention and screening programs. On March 1, supporters gathered in Raleigh, N.C. to kick off Colorectal Cancer Awareness month with their local Get Your Rear in Gear event.
The lab of Klaus Hahn, PhD, developed a new technique to help scientists map the interactions between the proteins at the heart of many diseases.
Parham is being recognized by the Society for Gynecologic Oncology for his work on cervical cancer and selfless dedication to improving the lives of women in Zambia.
Beth Knight found out what transpires inside cells involved in medulloblastoma - a type of brain cancer - and what role a particular protein plays in tumor development.
The program prepares volunteers to provide patients and their families with practical and emotional guidance as they receive treatment.
Two UNC researchers design a biological test to individualize chemotherapy.
UNC Lineberger Comprehensive Cancer Center member Jared Weiss, MD is teaming up with the cancer advocacy organization Global Resource for Advancing Cancer Education (GRACE) to offer a free webinar
UNC Lineberger members make major contribution to President’s Cancer Panel report on HPV vaccination
Members of the University of North Carolina Lineberger Comprehensive Cancer Center played a major role in developing the recommendations in a President’s Cancer Panel (PCP) report urging a widespread public campaign to increase the rate of human papillomavirus (HPV) vaccination.
The work of UNC School of Medicine Professor and Lineberger member John Baron, MD, is featured in an article titled "Can aspiring fight cancer?" The article provides an overview of recent studies that suggest regular doses of aspirin can help prevent some types of cancer.
The oncogene RAS is linked to 30 percent of human cancers, but the search for a targeted therapy for RAS has remained elusive. Three leading RAS researchers from the University of North Carolina Lineberger Comprehensive Cancer Center are playing leading roles at a conference aimed at discussing recent advances that may lead to new advances in targeting the oncogene.
Clinical trials that show positive patient response to systemic therapies for cancer should not necessarily lead to reduction in the use of local therapies such as radiation and surgery.
The Lung Cancer Initiative of North Carolina (LCINC), the state’s leading non-profit organization supporting lung cancer research and education, is proud to welcome Dr. Jared Weiss, medical oncologist with UNC Lineberger Comprehensive Cancer Center’s Thoracic Oncology Program, to serve on the board of directors.
UNC Lineberger member Russell Harris, MD, MPH, Professor of Medicine in the UNC School of Medicine and Adjunct Professor of Epidemiology in the UNC Gillings Global School of Public Health, was quoted in two articles in the New York Times about a major study of the efficacy of breast cancer screening published by BMJ (formerly British Medical Journal).
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.